Table 2 Treatment characteristics for patients undergoing preoperative chemoradiotherapy for gastric adenocarcinoma (n = 48)
From: Preoperative chemoradiotherapy for locally advanced gastric cancer
Characteristic | No. | % |
|---|---|---|
Concurrent chemotherapy | ||
5-FU or Capecitabine | 19 | 40 |
5-FU/Carboplatin/Paclitaxel | 11 | 23 |
5-FU/Cisplatin | 6 | 13 |
5-FU/Mitomycin C | 3 | 6 |
5-FU/Methotrexate | 1 | 2 |
Cisplatin/Paclitaxel | 6 | 13 |
Carboplatin/Paclitaxel | 2 | 4 |
Surgical procedure | ||
Total gastrectomy | 13 | 27 |
Partial gastrectomy | 9 | 19 |
Esophagogastrectomy | ||
Transhiatal | 5 | 10 |
Ivor-Lewis | 4 | 8 |
Sweet | 3 | 6 |
McKeown | 1 | 2 |
Not specified | 1 | 2 |
No surgical resection | 12 | 25 |